Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B.
Treatment of bacterial lipopolysaccharides (endotoxins) isolated from Salmonella minnesota R595 or purified lipid A with the antibiotic polymyxin B has been demonstrated to abrogate the ability of these molecules to activate serum complement. The inhibition is a function of the ratio of polymyxin B...
Spremljeno u:
| Izdano u: | Infect Immun |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1976
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC420610/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/175019/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.13.1.298-301.1976 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|